Novavax shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Novavax (NVAX) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Novavax
Tip: Access up to 7 years of quarterly data
All positions including Novavax held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Novavax by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $117k | 17k | 6.72 |
| 2025-09-30 | $89k | 10k | 8.67 |
| 2025-03-31 | $330k | 52k | 6.41 |
| 2024-06-30 | $319k | 25k | 12.66 |
| 2023-09-30 | $603k | 83k | 7.24 |
| 2023-06-30 | $209k | 28k | 7.43 |
| 2022-06-30 | $791k | 15k | 51.45 |
| 2022-03-31 | $2.2M | 29k | 73.65 |
| 2021-09-30 | $1.0M | 4.8k | 207.39 |
| 2020-09-30 | $1.5M | 13k | 108.36 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management